Antibiotic-free plasmids
US-9217153-B2 · Dec 22, 2015 · US
US9982286B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9982286-B2 |
| Application number | US-201615235453-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 12, 2016 |
| Priority date | Sep 28, 1999 |
| Publication date | May 29, 2018 |
| Grant date | May 29, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medium is described for the protein-free and serum-free cultivation of cells, especially mammalian cells, whereby the medium contains a proportion of soy hydrolysate.
Opening claim text (preview).
What is claimed is: 1. A method for increasing productivity of a recombinant protein in a cell culture, the method comprising: culturing mammalian cells that express the recombinant protein in an animal protein-free and serum-free cell culture medium; and adding more than 10 wt. % ultrafiltered soy hydrolysate based on the total dry weight of the medium to the animal protein-free and serum-free cell culture medium, wherein at least 40% of the soy hydrolysate has a molecular weight of ≤500 daltons. 2. The method of claim 1 , wherein at least 50% of the soy hydrolysate has a molecular weight of ≤500 daltons. 3. The method of claim 1 , wherein at least 55% of the soy hydrolysate has a molecular weight of ≤500 daltons. 4. The method of claim 1 , wherein the soy hydrolysate has an endotoxin content of <500 U/g. 5. The method of claim 1 , wherein the mammalian cells are CHO cells or BHK cells. 6. The method of claim 1 , wherein the recombinant protein is selected from the group consisting of: Factor II, Factor V, Factor VII, Factor VIII, Factor IX, Factor X, Factor XI, Protein S, Protein C, activated forms of these factors, and vWF. 7. The method of claim 6 , wherein the recombinant protein is Factor VIII. 8. The method of claim 1 , wherein the medium comprises an amino acid. 9. The method of claim 8 , wherein the amino acid is selected from the group consisting of L-asparagine, L-cysteine, L-cystine, L-proline, L-tryptophan, L-glutamine and mixtures thereof. 10. The method of claim 1 , wherein the medium further comprises: 1 to 100 g/L synthetic minimal medium; 0.05-1 g/L glutamine; 0.0005-0.05 g/L ascorbic acid; 0.1-10 g/L NaHCO 3 ; 0.0005-0.05 g/L ethanolamine; and 1-15 μg/L sodium selenite. 11. The method of claim 1 , wherein the cells are cultured in a bioreactor.
from plants · CPC title
Serum-free medium, which may still contain naturally-sourced components · CPC title
Protein-free medium · CPC title
Amines, e.g. putrescine · CPC title
Inorganic components · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.